CAS No.1333390-56-9 | Regorafenib iMpurity
CAS No.1333390-56-9 | Regorafenib iMpurity
CAS No.1333390-56-9 | Regorafenib iMpurity
+
  • CAS No.1333390-56-9 | Regorafenib iMpurity
  • CAS No.1333390-56-9 | Regorafenib iMpurity
  • CAS No.1333390-56-9 | Regorafenib iMpurity

CAS No.1333390-56-9 | Regorafenib iMpurity

Name: Regorafenib iMpurity CAS No. 1333390-56-9 MF:C14H9ClF4N2O2 MW:348.68 Purity:98% Package: 1mg,5mg,25mg,100mg,250mg Worldwide Delivery

Categories:

Analytical Chemicals

Product introduction

Introduction and application of  CAS No. 1333390-56-9 | Regorafenib iMpurity

 

Synonyms:RegorafenibMonohydrateImpurity;

RegorafenibMonohydrateIMP;

RegorafenibImpurity30;

Regorafenibimpurity3/RegorafenibUreaImpurity/1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea;

RegorafenibUreaImpurity;

Urea,N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(2-fluoro-4-hydroxyphenyl)-;

AFP-CTFureaimpurity(Regorafenibimpurity)

 

Specification:

ITEMS

SPECIFICATION

CAS

1333390-56-9

MF

C14H9ClF4N2O2

MW

348.68

Boiling point

346.9±42.0 °C

Density

1.599±0.06 g/cm3

Acidity coefficient

9.21±0.31

 

Purpose: The impurity 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-fluoro-4-hydroxyphenyl)urea is produced during the production of regorafenib. This produces impurities with the structure shown below. Regorafenib is a new multi-kinase inhibitor developed by Bayer. It targets tumor formation, tumor angiogenesis and the maintenance of tumor microenvironment signaling by inhibiting a variety of protein kinases that promote tumor growth. .

 

Package and transportation :

Package: 1mg,5mg,25mg,100mg,250mg

Transportation: by courier/ by air/ by se

Key words:

Related Products

Related Products

Inquiry

SUBMIT